{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-289829","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.467390+00:00","generated_at":"2026-06-28T23:59:25.600113+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cue Biopharma enters $80M at-the-market equity offering agreement with Jefferies","bullets":["Company enters Open Market Sale Agreement with Jefferies LLC to sell up to $80M of common stock at-the-market.","Prior $40M ATM agreement with Stifel terminated; $33.4M in gross proceeds realized from 2,099,700 shares sold.","Jefferies will receive 3.0% commission on gross proceeds from sales under the new agreement.","Shares will be sold under existing shelf registration statement; prospectus supplement filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-289829","json":"https://secwatch.observer/filing/0001193125-21-289829.json","markdown":"https://secwatch.observer/filing/0001193125-21-289829.md","text":"https://secwatch.observer/filing/0001193125-21-289829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/0001193125-21-289829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/d197369d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:59:25.600113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}